Stay updated on ABI-H0731 Combo vs Entecavir Alone in cHBV Clinical Trial
Sign up to get notified when there's something new on the ABI-H0731 Combo vs Entecavir Alone in cHBV Clinical Trial page.

Latest updates to the ABI-H0731 Combo vs Entecavir Alone in cHBV Clinical Trial page
- CheckyesterdayChange DetectedA minor metadata update replaces Revision: v3.4.0 with v3.4.1. No changes to study data, navigation, or visible page content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check23 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedNew study locations were added (California, Maryland, New York, Pennsylvania, British Columbia, Ontario) and the revision tag updated. Some previously listed location groupings were removed.SummaryDifference0.7%

- Check74 days agoChange DetectedAdded a note clarifying that the Publications section is automatically populated from PubMed and may include items not related to the study. Updated the page revision from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check81 days agoChange DetectedThe government funding status notice at the top of the page was removed. This change does not affect study data, eligibility criteria, or outcomes.SummaryDifference0.3%

- Check96 days agoChange DetectedThe screenshots show only minor UI/layout updates to the Study Details page with no changes to study content, status, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ABI-H0731 Combo vs Entecavir Alone in cHBV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABI-H0731 Combo vs Entecavir Alone in cHBV Clinical Trial page.